Therefore, reducing the overproduction of 27-OH using inhibitors for the enzyme responsible for converting cholesterol to 27-OH, Cyp27A1, may be a possible preventive strategy to reduce the risk of dementia or to improve therapies restoring neuronal function in neurodegeneration. The gene discussed is CYP27A1; the disease is dementia.